DexCom Basic EPS 2010-2025 | DXCM
DexCom annual/quarterly basic eps history and growth rate from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- DexCom basic eps for the quarter ending March 31, 2025 was $0.27, a 28.95% decline year-over-year.
- DexCom basic eps for the twelve months ending March 31, 2025 was $1.35, a 18.18% decline year-over-year.
- DexCom annual basic eps for 2024 was $0.001B, a 4.29% increase from 2023.
- DexCom annual basic eps for 2023 was $0.001B, a 59.09% increase from 2022.
- DexCom annual basic eps for 2022 was $0.001B, a 57.14% increase from 2021.
| DexCom Annual Basic EPS | |
|---|---|
| 2024 | $1.46 |
| 2023 | $1.40 |
| 2022 | $0.88 |
| 2021 | $0.56 |
| 2020 | $1.46 |
| 2019 | $0.28 |
| 2018 | $-0.36 |
| 2017 | $-0.15 |
| 2016 | $-0.20 |
| 2015 | $-0.18 |
| 2014 | $-0.08 |
| 2013 | $-0.11 |
| 2012 | $-0.20 |
| 2011 | $-0.17 |
| 2010 | $-0.24 |
| 2009 | $-0.30 |
| DexCom Quarterly Basic EPS | |
|---|---|
| 2025-03-31 | $0.27 |
| 2024-12-31 | $0.38 |
| 2024-09-30 | $0.34 |
| 2024-06-30 | $0.36 |
| 2024-03-31 | $0.38 |
| 2023-12-31 | $0.66 |
| 2023-09-30 | $0.31 |
| 2023-06-30 | $0.30 |
| 2023-03-31 | $0.13 |
| 2022-12-31 | $0.24 |
| 2022-09-30 | $0.26 |
| 2022-06-30 | $0.13 |
| 2022-03-31 | $0.25 |
| 2021-12-31 | $-0.02 |
| 2021-09-30 | $0.23 |
| 2021-06-30 | $0.20 |
| 2021-03-31 | $0.15 |
| 2020-12-31 | $1.10 |
| 2020-09-30 | $0.19 |
| 2020-06-30 | $0.12 |
| 2020-03-31 | $0.06 |
| 2019-12-31 | $0.26 |
| 2019-09-30 | $0.13 |
| 2019-06-30 | $-0.03 |
| 2019-03-31 | $-0.08 |
| 2018-12-31 | $-0.51 |
| 2018-09-30 | $0.13 |
| 2018-06-30 | $0.09 |
| 2018-03-31 | $-0.07 |
| 2017-12-31 | $-0.03 |
| 2017-09-30 | $-0.01 |
| 2017-06-30 | $0.01 |
| 2017-03-31 | $-0.12 |
| 2016-12-31 | $-0.02 |
| 2016-09-30 | $-0.06 |
| 2016-06-30 | $-0.06 |
| 2016-03-31 | $-0.06 |
| 2015-12-31 | $0.01 |
| 2015-09-30 | $-0.13 |
| 2015-06-30 | $-0.01 |
| 2015-03-31 | $-0.04 |
| 2014-12-31 | $0.01 |
| 2014-09-30 | $-0.02 |
| 2014-06-30 | $-0.02 |
| 2014-03-31 | $-0.04 |
| 2013-12-31 | $-0.01 |
| 2013-09-30 | $-0.02 |
| 2013-06-30 | $-0.04 |
| 2013-03-31 | $-0.04 |
| 2012-12-31 | $-0.03 |
| 2012-09-30 | $-0.06 |
| 2012-06-30 | $-0.05 |
| 2012-03-31 | $-0.05 |
| 2011-12-31 | $-0.05 |
| 2011-09-30 | $-0.05 |
| 2011-06-30 | $-0.03 |
| 2011-03-31 | $-0.05 |
| 2010-12-31 | $-0.04 |
| 2010-09-30 | $-0.06 |
| 2010-06-30 | $-0.05 |
| 2010-03-31 | $-0.10 |
| 2009-12-31 | $-0.07 |
| 2009-09-30 | $-0.07 |
| 2009-06-30 | $-0.08 |
| 2009-03-31 | $-0.08 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $32.004B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $189.754B | 83.11 |
| Thermo Fisher Scientific (TMO) | United States | $159.887B | 19.34 |
| Alcon (ALC) | Switzerland | $48.486B | 32.23 |
| Edwards Lifesciences (EW) | United States | $44.472B | 29.10 |
| IDEXX Laboratories (IDXX) | United States | $37.951B | 43.61 |
| IQVIA Holdings (IQV) | United States | $27.061B | 14.97 |
| Mettler-Toledo (MTD) | United States | $22.925B | 27.19 |
| STERIS (STE) | Ireland | $22.088B | 25.26 |
| Waters (WAT) | United States | $20.850B | 29.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.568B | 0.00 |
| Hologic (HOLX) | United States | $12.153B | 13.11 |
| Sysmex ADR (SSMXY) | Japan | $11.545B | 0.00 |
| Penumbra (PEN) | United States | $11.463B | 89.97 |
| Globus Medical (GMED) | United States | $9.891B | 22.90 |
| Masimo (MASI) | United States | $8.993B | 37.74 |
| Teleflex (TFX) | United States | $5.586B | 9.22 |
| Glaukos (GKOS) | United States | $5.006B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.385B | 22.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.077B | 0.00 |
| TransMedics (TMDX) | United States | $3.044B | 89.09 |
| Veracyte (VCYT) | United States | $2.377B | 42.75 |
| Nihon Kohden (NHNKY) | Japan | $2.113B | 11.55 |
| LivaNova (LIVN) | United Kingdom | $2.005B | 12.14 |
| Elekta AB (EKTAY) | Sweden | $1.960B | 17.62 |
| Alphatec Holdings (ATEC) | United States | $1.754B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.431B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.302B | 6.58 |
| Pulse Biosciences (PLSE) | United States | $1.156B | 0.00 |
| OPKO Health (OPK) | United States | $1.098B | 0.00 |
| Artivion (AORT) | United States | $0.996B | 93.32 |
| AxoGen (AXGN) | United States | $0.780B | 0.00 |
| IRadimed (IRMD) | United States | $0.680B | 35.65 |
| Mesa Laboratories (MLAB) | United States | $0.647B | 14.14 |
| RxSight (RXST) | United States | $0.644B | 0.00 |
| SiBone (SIBN) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.565B | 9.10 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.513B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.457B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.36 |
| Pacific Biosciences Of California (PACB) | United States | $0.339B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.333B | 17.82 |
| Neuronetics (STIM) | United States | $0.301B | 0.00 |
| CVRx (CVRX) | United States | $0.207B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.194B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.183B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.160B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.158B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 10.82 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |